We are live on
!
Find out more
BS
Bow Street Portfolio holdings
AUM
$52.4M
1-Year Est. Return
2.22%
This Fund
S&P 500
This Quarter
Est. Return
-14.94%
1 Year Est. Return
-2.22%
3 Year Est. Return
+43.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$34.6M
AUM Growth
+$9.97M
(+40%)
Cap. Flow
+$17.2M
Cap. Flow
% of AUM
49.8%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
1
Increased
1
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NRE
NorthStar Realty Europe Corp.
NRE
|
+$9.2M |
| 2 |
ADMS
Adamas Pharmaceuticals
ADMS
|
+$8.02M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|
Similar funds
LSVM
RVGI
HPA
CCM
NHG
IAM
ACI
RAM
Bow Street's Q2 2016 Portfolio in Review
As of Q2 2016, Bow Street held 2 positions worth $34.6M, up 40% from $24.6M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Bow Street deployed $17.2M of net new capital in Q2 2016, opening 1 new position and adding to 1 existing holding. Its largest new stake was Adamas Pharmaceuticals: 486,747 shares worth $7.37M.
- Bow Street's largest Q2 2016 buy was Adamas Pharmaceuticals: 486,747 shares worth $7.37M.
- Bow Street added most to NorthStar Realty Europe Corp. in Q2 2016, an estimated $9.2M increase.
- Bow Street's ten largest holdings make up 100% of its $34.6M portfolio in Q2 2016.
- Bow Street opened 1 new position and closed 0 in Q2 2016.
- Bow Street's portfolio value rose 40% quarter-over-quarter to $34.6M.
Based on Bow Street's 13F filing for Q2 2016, filed 15 Aug 2016.